World Drug Safety Congress Americas 2013

Developing and implementing the right drug safety strategy is one of the most pressing challenges facing
the biopharmaceutical industry today.

The 5th annual World Drug Safety Congress provides you with key insights into the drug safety challenges affecting you and gives you an excellent opportunity to discuss these diverse issues in a conference format.

Focus on...
• International drug safety landscape
• Global regulatory overview and recent developments
• Increasing complexities affecting the management of drug safety
• Data management and electronic submissions
• Financial and logistical constraints
• In-depth look at clinical safety & the limitations to pre-marketing safety

Speakers
David Balderson,Paul Beninger,Cristina Damatarca MD,Peter de Veene,
Reinerio Deza,Hoda Eid, M.Sc., Ph.D.,Michael Forstner,Stephen Furlong,
Robin Geller and many more.